Peptide Hubs
Latest laboratory result 4.78 mg/vial September 29, 2025 · 95.60% of 5 mg label claim · Batch #CJCND8 View
You will save $22.00
CJC 1295 No DAC 5 mg
Product Details Peptide Hubs
Active Substance Modified GRF (1–29) Commonly called CJC-1295 No DAC
Strength 5 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class GHRH analogue
Peptide Length 29 amino acids
Human Half-Life Not established Short-acting, no DAC
Primary Target GHRH receptor GH-axis research
$33.00
$55.00
Shipping Location :
International
U.S. Domestic
Premium CJC-1295 No DAC 5mg by Peptide Hubs
Experience the power of precise growth hormone stimulation with Peptide Hubs' CJC-1295 No DAC 5mg. This advanced peptide, also known as Modified GRF 1-29, represents the cutting edge of growth hormone-releasing hormone (GHRH) analogs. Unlike its DAC-bound counterpart, CJC-1295 No DAC provides rapid, pulsatile growth hormone release that closely mimics the body's natural secretion patterns without extended activity.
Scientific Precision of Modified GRF 1-29
CJC-1295 No DAC is a modified version of the native Growth Hormone-Releasing Hormone (GHRH) fragment comprising the first 29 amino acids. The modification includes the replacement of the second amino acid (alanine) with aspartic acid, significantly enhancing stability and bioavailability while maintaining full biological activity. This precise modification creates a peptide resistant to dipeptidyl peptidase IV degradation, extending its half-life compared to the native GHRH (1-29) while preserving the natural pulsatile release pattern.
According to research published in the National Institutes of Health, GHRH analogs like Modified GRF 1-29 stimulate growth hormone secretion through specific pituitary receptors, activating the cAMP pathway and ultimately increasing both GH production and release. This mechanism produces a physiological pulse pattern that differs from the non-pulsatile, sustained elevation seen with long-acting GHRH analogs or exogenous growth hormone administration.
Benefits for Discerning Athletes
Natural Pulsatile GH Release
Mimics the body's natural growth hormone secretion pattern for physiological results with minimal side effects.
Enhanced Fat Metabolism
Promotes lipolysis and reduces adipose tissue, particularly stubborn abdominal fat, without catabolic effects.
Improved Recovery Capacity
Accelerates recovery between training sessions through enhanced protein synthesis and cellular repair.
Sleep Quality Enhancement
When administered before bedtime, increases deep sleep phases and maximizes natural nocturnal GH pulses.
For those seeking complementary peptides, consider our GHRP-2 which offers powerful growth hormone releasing effects through a different mechanism of action.
Technical Details
Peptide Type
Modified GHRH Analogue
Peptide Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NHâ
Peptide Length
29 Amino-Acid Residues
Structural Origin
Human GHRH(1–29) Analogue
Sequence Modifications
D-Ala² · Gln⸠· Alaš⾠· Leu²âˇ
Terminal Form
C-Terminally Amidated (-NHâ)
Molecular Formula
Cââ
âHââ
âNââOââ
Molecular Weight
3367.9 g/mol
PubChem CID
91976842
Primary Receptor
GHRH Receptor (GHRHR)
DAC Modification
None · No Drug Affinity Complex
Research Status
Experimental / Research Compound
Dosage & Usage Guidelines
Reconstitute the lyophilized powder with bacteriostatic water before administration. The typical dosage ranges from 100-300 mcg, administered 1-3 times daily. Due to its short half-life (approximately 30 minutes), timing is crucial for optimal results. Most users experience best outcomes with administration on an empty stomach—upon waking, pre-workout, and especially before bedtime to coincide with the body's natural nocturnal growth hormone surge. Avoid administering immediately after meals as elevated blood glucose can blunt the growth hormone response.
For optimal results, consider pairing with our Sterile Bacteriostatic Water (10ml) which provides the ideal solvent for peptide reconstitution and preservation.
Cycle Information and Stacking Options
Typical cycles range from 8-12 weeks, followed by a 4-week break to prevent receptor desensitization. Most users report noticeable improvements in recovery and sleep quality within the first 1-2 weeks, with visible body composition changes becoming apparent within 4-6 weeks. For enhanced results, CJC-1295 No DAC can be effectively stacked with growth hormone secretagogues (GHSs) that work through different mechanisms.
Consider combining with Ipamorelin for a powerful growth hormone-releasing combination that mimics natural secretion patterns, or with Mechano Growth Factor (MGF) for targeted muscle repair and localized growth stimulation.
Important: This product is intended for research purposes only. Not for human consumption. Always consult with a healthcare professional before beginning any new supplement regimen.
Why Choose Peptide Hubs' CJC-1295 No DAC?
Our CJC-1295 No DAC undergoes rigorous third-party testing to ensure >99% purity, accurate peptide sequencing, and complete sterility. Each batch is manufactured in ISO-certified facilities using pharmaceutical-grade ingredients and advanced lyophilization technology. The result is a premium peptide product that delivers consistent, measurable results for serious athletes and researchers.
For those interested in other research compounds, explore our Epitalon for telomere support and cellular health, or our LL-37 for immune system modulation and antimicrobial research.
Peptide Hubs remains committed to providing the highest quality research peptides to the scientific community. Our CJC-1295 No DAC represents the pinnacle of peptide technology, offering researchers a precise tool for studying growth hormone dynamics without the extended activity profile of DAC-modified analogs.
Batch-Tested & Verified Lab Results
Shipping & Product Authenticity
USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery
This product is supplied through the official Peptide Hubs distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
What to Expect
- â Orders are processed after payment confirmation
- â USA Domestic shipping is typically faster when local stock is selected
- â International orders include tracking, though update frequency may vary by destination
- â Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Peptide Hubs presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.
After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
The primary difference lies in their half-lives and release profiles. CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in the bloodstream, extending its half-life to approximately 7-10 days and creating sustained GH release. CJC-1295 No DAC (Modified GRF 1-29) has a short half-life of about 30 minutes, producing brief, pulsatile GH releases that closely mimic the body's natural secretion pattern. The No DAC version allows for more precise timing of GH pulses and avoids the continuous elevation seen with the DAC version.
When is the optimal time to administer CJC-1295 No DAC?
The most effective administration times are on an empty stomachâtypically upon waking, pre-workout, and especially before bedtime. The pre-bedtime administration is particularly important as it coincides with the body's natural nocturnal growth hormone surge. Avoid administering immediately after meals (wait 2-3 hours post-meal) as elevated blood glucose and insulin levels can blunt the growth hormone response. Due to its short half-life, timing is more critical with CJC-1295 No DAC than with longer-acting peptides.
Can CJC-1295 No DAC be combined with other peptides?
Yes, CJC-1295 No DAC is frequently and effectively combined with growth hormone secretagogues (GHSs) like GHRP-6, GHRP-2, or Ipamorelin. These combinations create a synergistic effect as they work through different mechanismsâCJC-1295 No DAC stimulates GH release through GHRH receptors, while GHSs work through ghrelin receptors. This dual approach often produces a greater GH release than either compound alone. Many users report excellent results with a 100-300 mcg dose of each peptide administered simultaneously.
What results can I expect from using CJC-1295 No DAC?
Users typically notice improved sleep quality and enhanced recovery within the first 1-2 weeks. Visible fat loss, especially around the abdominal area, becomes apparent within 4-6 weeks. Full cycle results include significantly improved muscle definition, reduced body fat, enhanced recovery between workouts, improved skin texture and elasticity, and increased lean muscle mass. The pulsatile nature of CJC-1295 No DAC means it produces more natural, physiological results compared to sustained-release compounds.
Are there any side effects associated with CJC-1295 No DAC?
CJC-1295 No DAC is generally well-tolerated with an excellent safety profile. Some users report temporary flushing, lightheadedness, or tingling sensations shortly after injectionâthese typically subside within 30 minutes. Unlike traditional GH therapy or long-acting GHRH analogs, CJC-1295 No DAC does not cause water retention, joint pain, or carpal tunnel syndrome due to its pulsatile release pattern. The modified structure also reduces potential histamine responses compared to some other peptides.
Related Offers
Lab Tested
Domestic & International
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Substance Ipamorelin
Strength 5 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class GH secretagogue
Peptide Length 5 amino acids Pentapeptide
Terminal Half-Life ~2 hours
Primary Target GHS-R Ghrelin receptor pathway
$26.40
$44.00
Lab Tested
Domestic & International
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Formula Per vial
Thymosin Beta-4β-Thymosin peptide
5 mgBPC-157Synthetic pentadecapeptide
5 mgTotal Strength 10 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Multi-peptide blend
Research Focus Tissue repair Regenerative research
Human PK Not established For combined formulation
$45.00
$75.00
Lab Tested
Domestic & International
NEW
-40% OFF
Peptide Hubs
Product Details Peptide Hubs
Active Substance GHK-Cu Copper tripeptide-1
Strength 50 mg/vial
Vial Size 2 mL vial
Form Lyophilized powder For reconstitution
Research Class Copper-binding peptide
Peptide Sequence Gly-His-Lys Tripeptide
Copper Complex Cu2+
Human Half-Life Not established
$27.00
$45.00